Chemical inhibitors of OR6C76 include a variety of compounds that interact with the protein and its associated cellular pathways to inhibit its function. Zinc acetate can disrupt OR6C76 by binding to its metal ion binding sites, which are often crucial for the structural integrity and proper function of olfactory receptors. This binding can lead to a conformational change in OR6C76, rendering it unable to detect odorant molecules. Similarly, Copper(II) sulfate can bind to OR6C76's active site, which is directly involved in its signaling function, and inhibit the receptor's ability to transduce olfactory signals. Chloroquine's role in embedding within cell membranes can change membrane properties, potentially altering OR6C76's configuration and thus inhibiting its activity.
Lidocaine and tetraethylammonium provide examples of inhibitors that target neuronal excitability. Lidocaine stabilizes the inactive state of sodium channels in olfactory neurons, which reduces the excitability of the neurons that express OR6C76, leading to reduced signal propagation. Tetraethylammonium blocks potassium channels that are essential for the excitability of neurons, and this reduction in neuron excitability can indirectly inhibit the signaling processes of OR6C76. Quinine, by blocking ion channels involved in olfactory signal transduction, leads to a decreased response from OR6C76. Calcium channel inhibitors like Ruthenium red, Verapamil, Diltiazem, and Nifedipine disrupt calcium-dependent signaling pathways crucial for the function of OR6C76. These inhibitors block the influx of calcium ions that would otherwise contribute to the intracellular signaling cascades necessary for OR6C76's function. Amiloride contributes to the inhibition of OR6C76 by targeting sodium channels and hindering depolarization, which is a crucial step in the olfactory signaling process involving OR6C76. Lastly, Methylene blue disrupts the activity of guanylyl cyclase, reducing the levels of cyclic guanosine monophosphate (cGMP), which plays a pivotal role in the signaling pathways of olfactory receptors including OR6C76, therefore inhibiting its function. Each of these chemicals interacts with OR6C76 or its associated pathways to inhibit the protein's ability to function as an olfactory receptor.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Zinc | 7440-66-6 | sc-213177 | 100 g | $48.00 | ||
Zinc acetate can bind to metal ion binding sites on OR6C76, which may be crucial for its structure or function, leading to altered conformation and inhibition of the receptor's ability to detect odorants. | ||||||
Copper(II) sulfate | 7758-98-7 | sc-211133 sc-211133A sc-211133B | 100 g 500 g 1 kg | $46.00 $122.00 $189.00 | 3 | |
Copper(II) sulfate can interact with active sites on OR6C76, essential for its signaling function, thus directly inhibiting its olfactory signal transduction capabilities. | ||||||
Chloroquine | 54-05-7 | sc-507304 | 250 mg | $69.00 | 2 | |
Chloroquine embeds itself in cell membranes, which can alter the membrane properties and affect OR6C76's configuration, leading to inhibition of its activity. | ||||||
Lidocaine | 137-58-6 | sc-204056 sc-204056A | 50 mg 1 g | $51.00 $131.00 | ||
Lidocaine stabilizes the inactive configuration of sodium channels in olfactory neurons, which reduces the ability of OR6C76 to propagate olfactory signals. | ||||||
Quinine | 130-95-0 | sc-212616 sc-212616A sc-212616B sc-212616C sc-212616D | 1 g 5 g 10 g 25 g 50 g | $79.00 $104.00 $166.00 $354.00 $572.00 | 1 | |
Quinine blocks ion channels involved in olfactory signal transduction pathways, resulting in a decreased response from OR6C76. | ||||||
Ruthenium red | 11103-72-3 | sc-202328 sc-202328A | 500 mg 1 g | $188.00 $250.00 | 13 | |
Ruthenium red obstructs calcium channels, which are vital to the signaling pathways of olfactory receptors like OR6C76, leading to functional inhibition. | ||||||
Verapamil | 52-53-9 | sc-507373 | 1 g | $374.00 | ||
Verapamil blocks L-type calcium channels, crucial for the signal cascade in olfactory neurons expressing OR6C76, reducing the receptor's function. | ||||||
Diltiazem | 42399-41-7 | sc-204726 sc-204726A | 1 g 5 g | $209.00 $464.00 | 4 | |
Diltiazem inhibits OR6C76 by blocking L-type calcium channels, which are important for neuron signaling processes that involve this receptor. | ||||||
Nifedipine | 21829-25-4 | sc-3589 sc-3589A | 1 g 5 g | $59.00 $173.00 | 15 | |
Nifedipine inhibits OR6C76 by blocking calcium channels, decreasing the intracellular calcium necessary for the receptor's signaling process. | ||||||
Amiloride | 2609-46-3 | sc-337527 | 1 g | $296.00 | 7 | |
Amiloride inhibits OR6C76 by blocking sodium channels essential for depolarization in olfactory signal transduction involving this receptor. | ||||||